Army to announce it has developed a single vaccine that protects from ALL variants of COVID and SARS

Walter Reed Army Institute of Research is set to announce the development of a vaccine that is effective against all COVID and SARS variants Army researchers at Walter Reed have been working on a vaccine for two years The Spike Ferritin Nanoparticle COVID-19 vaccine (SpFN) has so far been proven to protect against all existing and potential variants of the viruses The Omicron COVID variant has been quickly spreading across the world and now accounts for 73 per cent of all new diagnoses in the US Some states including New York and neighboring New Jersey say the super-infectious variant is behind 90 per cent of positive cases there

3
833

UK Daily Mail: After nearly two years, scientists at the Walter Reed Army Institute of Research believe they have developed a vaccine that is effective against all COVID and SARS variants.

Researchers at the Maryland-based facility expect to officially announce the completion of the vaccine in the coming weeks, Defense One first reported.

News of the new super-vaccine comes as the latest COVID variant, Omicron, drives a fresh explosion in cases across the US, just weeks after it was first spotted in a California COVID patient on December 1. It now accounts for 73 per cent of all diagnoses across the country, with the figure as high as 90 per cent in states including New York and New Jersey.

On Monday night, the United States confirmed its first Omicron death, a man in his 50s from Houston who was unvaccinated and had previously recovered from COVID before being infected again and dying.

The Army began working on the Spike Ferritin Nanoparticle COVID-19 vaccine (SpFN) in early 2020, with a final release date likely to emerge whenever the Army submits its trial results to the Food and Drug Administration. It also remains unclear whether SpFN will be a single or multiple-shot vaccine.



From the beginning, they worked to create a vaccine that would protect against all existing and potential variants of the viruses. Read more…

https://www.dailymail.co.uk/news/article-10335105/Army-announce-developed-single-vaccine-protects-variants-COVID-SARS.html

ATTENTION READERS

We See The World From All Sides and Want YOU To Be Fully Informed
In fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.

About VT - Policies & Disclosures - Comment Policy
Due to the nature of uncensored content posted by VT's fully independent international writers, VT cannot guarantee absolute validity. All content is owned by the author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners, or technicians. Some content may be satirical in nature. All images are the full responsibility of the article author and NOT VT.

3 COMMENTS

  1. It is actually against our security interests to have the best vaccine being sold by Pfizer at 30 bucks a pop, and then booster after booster, just smells like impropriety. If the Army beat a pharma company to a one shot vaccine that covers all variants, we have a massive conundrum. I personally find it very hard to believe. It is more likely, that pharma’s are not being honest with us, as every person intuits.

    The people have paid plenty, and nobody should be profiting off of it. On moderna’s own front page “In October 2013, DARPA awarded Moderna up to approximately $25 million to research and develop potential mRNA medicines as a part of DARPA’s Autonomous Diagnostics to Enable Prevention and Therapeutics, or ADEPT, program, which is focused on assisting with the development of technologies to rapidly identify and respond to threats posed by natural and engineered diseases and toxins. This award followed an initial award from DARPA given in March 2013. The DARPA awards have been deployed primarily in support of our vaccine and antibody programs to protect against Chikungunya infection.”

    • Not sure if this is a proper analogy, but if I pay Bob, to build me a shed, that is my shed.

      An economic and national security question, if public money is used to develop anything, is not our agreement, that the public owns it ? If the polio vaccine patent was released, then why not covid vaccine ?

    • Dave. You know how the shell game works. While the sucker is distracted by the hustlers rap and quick hands, the prize is mysteriously off the table. Of course, there never really is a prize in play. The vaccines are just another shell game. It can go on forever unless the chumps demand to see what’s under the table.

Comments are closed.